Risk of Recurrence in Surgically Resected Stage I Adenocarcinoma of the Lung: Histopathologic and Immunohistochemical Analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00408-008-9116-4.pdf
Reference26 articles.
1. Travis WD, Colby TV, Corrin B (1999) Histological typing of lung and pleural tumors, 3rd edn. OMS Springer, Heidelberg
2. Mountain CF, Lukeman JM, Hammar SP (1987) Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol 35:147–156. doi: 10.1002/jso.2930350302
3. Nesbitt JC, Putnam JB Jr, Walsh GL, Roth JA, Mountain CF (1995) Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 60:466–472. doi: 10.1016/0003-4975(95)00169-L
4. Cox G, Jones JL, Andi A, Waller DA, O’Byme KJ (2001) A biological staging model for operable non-small cell lung cancer. Thorax 56:561–566. doi: 10.1136/thorax.56.7.561
5. Harpole DH Jr, Richards WG, Herndon JEII, Sugarbaker DJ (1996) Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann Thorac Surg 61:1470–1476. doi: 10.1016/0003-4975(96)00104-X
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinicopathological, gene expression and genetic features of stage I lung adenocarcinoma with necrosis;Lung Cancer;2021-09
2. Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer;Medicine;2021-02-19
3. 18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer;European Journal of Nuclear Medicine and Molecular Imaging;2019-06-18
4. Identification of SPP1 as a promising biomarker to predict clinical outcome of lung adenocarcinoma individuals;Gene;2018-12
5. BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis;Journal of Thoracic Oncology;2018-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3